Complete Filing Data
Evotec SE reported Number Of Shares Issued of 177.55 million shares for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Evotec SE did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Selling General And Administrative Expense | $188.2M | $169.6M | $156.2M | $105.4M | $77.2M | $66.4M |
| Research And Development Expense | $50.9M | $68.5M | $76.6M | $72.2M | $63.9M | $58.4M |
| Profit Loss From Operating Activities | -$142.5M | -$47.5M | $20.9M | $41.0M | $48.6M | $62.7M |
| Profit Loss Before Tax | -$194.0M | -$80.6M | -$154.0M | $237.0M | $25.8M | $56.7M |
| Profit Loss | -$196.1M | -$83.9M | -$175.7M | $215.5M | $6.3M | $37.3M |
| Other Operating Expenses | $16.1M | $44.2M | $2.0M | $5.7M | $5.0M | $9.9M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Plans | $1.2M | -$51.0K | $1.4M | $664.0K | -$580.0K | -$1.0M |
| Other Comprehensive Income Before Tax Financial Assets Measured At Fair Value Through Other Comprehensive Income | $2.1M | $10.1M | -$13.5M | -$1.9M | $126.0K | $135.0K |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | $23.1M | -$1.8M | -$598.0K | $26.1M | -$17.7M | $9.1M |
| Other Comprehensive Income | $23.3M | $6.8M | -$24.8M | $24.9M | -$18.0M | $7.6M |
| Income Tax Relating To Components Of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | $316.0K | -$13.0K | $357.0K | -$7.0K | -$149.0K | $525.0K |
| Income Tax Expense Continuing Operations | $2.1M | $3.3M | $21.7M | $21.5M | $19.6M | $19.4M |
| Gross Profit | $114.9M | $175.1M | $174.1M | $151.5M | $125.7M | $132.9M |
| Cost Of Sales | $682.1M | $606.4M | $577.4M | $466.5M | $375.2M | $313.5M |
| Comprehensive Income | -$172.8M | -$77.2M | -$200.4M | $240.4M | -$11.7M | $45.0M |
| Income Taxes Refund Classified As Operating Activities | $62.2M | $12.6M | $16.4M | $17.6M | $11.4M | $6.9M |
| Impairment Of Intangible Assets | $5.0M | $683.0K | $3.2M | $10.3M | ||
| Share Of Profit Loss Of Associates Accounted For Using Equity Method | -$16.0M | -$16.6M | -$10.4M | -$2.2M | ||
| Share Of Profit Loss And Reevaluation Of Associates And Joint Ventures Accounted For Using Equity Method | -$4.3M | -$20.8M | -$15.1M | -$16.6M | ||
| Revenue From Interest | $8.3M | $2.3M | $1.3M | $2.2M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $306.4M | $510.9M | $415.2M | $699.3M | $422.6M | $277.0M | $109.1M |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $117.5M | $213.3M | $181.4M | $118.9M | $99.1M | $31.3M | |
| Investment Accounted For Using Equity Method | $2.1M | $3.1M | $16.0M | $13.1M | $39.7M | $29.8M | |
| Gains Losses On Financial Assets At Fair Value Through Profit Or Loss | -$38.5M | -$9.1M | -$172.2M | $211.8M | $1.5M | $80.0K | |
| Cash Flows From Used In Operating Activities | $18.2M | $36.4M | $205.8M | $126.6M | $44.7M | $42.2M | |
| Cash Flows From Used In Investing Activities | -$71.2M | -$13.3M | -$412.8M | -$242.8M | -$155.1M | -$86.6M | |
| Cash Flows From Used In Financing Activities | -$161.4M | $72.0M | -$58.1M | $393.0M | $246.4M | $211.3M | |
| Noncurrent Contract Liabilities | $156.7M | $155.3M | $206.1M | $33.5M | $22.4M | ||
| Current Contract Liabilities | $106.6M | $97.6M | $122.9M | $112.1M | $66.5M | ||
| Current Contract Assets | $46.0M | $25.0M | $30.5M | $18.6M | $12.6M | ||
| Deferred And Current Tax On Future Deductible Expenses | -$301.0K | $708.0K | $676.0K | $1.8M | |||
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | -$2.1M | $20.9M | $410.0K | $10.9M | $40.3M | ||
| Retained Earnings | -$672.4M | -$476.3M | -$392.4M | -$216.4M | -$432.6M | ||
| Other Noncurrent Nonfinancial Assets | $3.5M | $837.0K | $3.8M | $870.0K | $892.0K | ||
| Other Current Nonfinancial Liabilities | $27.4M | $22.6M | $16.9M | $12.6M | $20.0M | ||
| Other Current Financial Assets | $4.3M | $12.8M | $11.5M | $264.0K | $10.7M | ||
| Noncurrent Liabilities | $615.4M | $668.0M | $732.4M | $533.0M | $529.4M | ||
| Noncurrent Assets | $1.23B | $1.35B | $1.18B | $1.13B | $803.5M | ||
| Net Deferred Tax Liabilities | $14.5M | $18.1M | $18.5M | $17.7M | $20.4M | ||
| Net Deferred Tax Assets | $17.3M | $14.3M | $10.3M | $17.4M | $24.4M | ||
| Equity And Liabilities | $1.91B | $2.25B | $2.26B | $2.24B | $1.46B | ||
| Current Tax Liabilities Current | $8.5M | $5.6M | $9.0M | $10.6M | $3.4M | ||
| Current Tax Assets Noncurrent | $34.4M | $94.4M | $70.3M | $56.0M | $36.5M | ||
| Current Tax Assets Current | $41.9M | $80.7M | $54.4M | $23.4M | $21.7M | ||
| Current Prepayments And Other Current Assets | $45.5M | $51.3M | $57.1M | $39.9M | $30.4M | ||
| Current Liabilities | $344.6M | $464.6M | $337.7M | $324.5M | $208.5M | ||
| Current Investments | $90.4M | $93.2M | $303.3M | $158.9M | $59.4M | ||
| Current Deferred Income Other Than Current Contract Liabilities | $3.2M | $10.3M | $13.7M | $14.7M | $4.2M | ||
| Current Assets | $682.0M | $903.2M | $1.07B | $1.10B | $658.8M | ||
| Assets | $1.91B | $2.25B | $2.26B | $2.24B | $1.46B | ||
| Accumulated Other Comprehensive Income | -$7.3M | -$30.6M | -$37.4M | -$12.6M | -$37.5M | ||
| Purchase Of Investments In Associated Companies And Other Long Term Investments | $58.8M | $20.7M | $22.7M | $11.7M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Payments Of Lease Liabilities Classified As Financing Activities | $24.1M | $22.4M | $19.0M | $20.7M | $20.2M | $12.9M |
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | -$214.4M | $95.1M | -$265.1M | $276.8M | $136.0M | $166.8M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $9.9M | $644.0K | -$19.0M | -$66.0K | $9.5M | $1.1M |
| Proceeds From Exercise Of Options | $368.0K | $219.0K | $344.0K | $1.2M | $1.6M | $1.9M |
| Proceeds From Borrowings Classified As Financing Activities | $900.0K | $219.9M | $30.8M | $21.5M | $292.3M | |
| Proceeds From Issuing Shares | 355.0K | 403.1M | 250.0M | |||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period | $345.0K | $1.2M | $1.5M | $1.8M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Number Of Shares Issued | 177.6M | 177.2M | 177.0M | 176.6M | 163.9M | 150.9M | 149.1M |
| Weighted Average Shares | 177.3M | 176.9M | 176.7M | 166.4M | 153.8M | 149.7M | |
| Diluted Earnings Loss Per Share | $-1.11 | $-0.47 | $-0.99 | $1.30 | $0.04 | $0.25 | |
| Basic Earnings Loss Per Share | $-1.11 | $-0.47 | $-0.99 | $1.30 | $0.04 | $0.25 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Total Operating Income And Expenses | -$257.4M | -$222.6M | -$153.2M | -$110.5M | -$77.2M | -$70.2M |
| Repayments Of Borrowings Classified As Financing Activities | $128.8M | $112.9M | $34.1M | $16.0M | $6.5M | $70.0M |
| Other Income | $52.7M | $64.8M | $81.6M | $73.5M | $72.2M | $76.5M |
| Increase Decrease Through Sharebased Payment Transactions | $5.0M | $9.6M | $9.9M | $7.8M | $5.3M | $3.7M |
| Increase Decrease Through Exercise Of Options | $368.0K | $233.0K | $345.0K | $1.2M | $1.6M | $1.9M |
| Adjustments For Sharebased Payments | $5.0M | $9.6M | $9.9M | $7.8M | $5.3M | $3.6M |
| Other Finance Income | $2.4M | $9.3M | $8.3M | $2.3M | $70.0K | $32.0K |
| Other Adjustments For Noncash Items | $23.7M | -$114.0K | -$16.0M | $4.4M | $0.00 | $59.0K |
| Other Finance Cost | $11.7M | $11.7M | $13.2M | $9.3M | $43.0K | |
| Noncurrent Provisions | $19.6M | $16.1M | $16.4M | $18.0M | $20.7M | |
| Issued Capital | $177.6M | $177.2M | $177.0M | $176.6M | $163.9M | |
| Inventories | $31.1M | $30.9M | $29.8M | $25.8M | $13.6M | |
| Current Provisions | $62.2M | $45.2M | $54.4M | $39.3M | $41.8M | |
| Additional Paidin Capital | $1.45B | $1.45B | $1.44B | $1.43B | $1.03B | |
| Total Non Operating Income Expense | -$174.8M | $196.0M | -$22.7M | -$6.0M |
Most recent annual filing with the SEC: April 17, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.